共 15 条
[1]
Llach F., Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisited, Am J Kidney Dis, 25, pp. 663-679, (1995)
[2]
Fukuda N., Tanaka H., Tominaga Y., Fukagawa M., Kurokawa K., Seino Y., Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients, J Clin Invest, 92, pp. 1436-1443, (1993)
[3]
Kifor O., Moore F.D., Wang P., Goldstein M., Vassilev P., Kifor I., Et al., Reduced immunostaining for the extracellular Ca<sup>2+</sup>-sensing receptor in primary and uremic secondary hyperparathyroidism, J Clin Endocrinol Metab, 81, pp. 1598-1606, (1996)
[4]
Tominaga Y., Tsuzuki T., Uchida K., Haba T., Otsuka S., Ichimori T., Et al., Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma, Kidney Int, 55, pp. 1375-1383, (1999)
[5]
Mizumoto D., Watanabe Y., Fukuzawa Y., Aoi N., Yamazaki C., Clinical profile and outcome of primary hyperparathyroidism accompanied by chronic renal failure, Clin Nephrol, 42, pp. 315-321, (1994)
[6]
Lawrence D.A., A histological comparison of adenomatous and hyperplastic parathyroid glands, J Clin Pathol, 31, pp. 626-632, (1978)
[7]
Smith J.F., Parathyroid adenomas associated with the malabsorption syndrome and chronic renal disease, J Clin Pathol, 23, pp. 362-369, (1970)
[8]
Kishi M., Tsukada T., Shimizu S., Hosono K., Ohkubo T., Kosuge T., Et al., A novel splicing mutation (894-9 G → A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1, Cancer Lett, 142, pp. 105-110, (1999)
[9]
Schussheim D.H., Skarulis M.C., Agarwal S.K., Simonds W.F., Burns A.L., Spiegel A.M., Et al., Multiple endocrine neoplasia type 1: New clinical and basic findings, Trends Endocrinol Metab, 12, pp. 173-178, (2001)
[10]
Stratakis C.A., Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes, J Endocrinol Invest, 24, pp. 370-383, (2001)